ALB and colorectal cancer: Following fruquintinib treatment, patients with colorectal cancer and high PNI levels demonstrated elevated levels of white blood cells, lymphocytes, basophils, red blood cells, hemoglobin, platelets, total protein, and albumin, indicative of a pronounced therapeutic effect and extended OS time.